hCG Tumor Marker

Last Modified: 3/27/2019 3:01:48 PM


  Medicare Medical Necessity Restrictions May Apply
Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements: 1.0 mL Serum from a Red Top Tube in a Plastic Vial
Collection Instructions:  
Minimum Volume: 0.3 mL
Transport & Storage: Temperature/Stability: 7 days Refrigerated
Reference Range:

Refer to interpretive report
Critical Ranges:  
Test Comments: All values > 4 and < 10 will have the following message applied, if the patient is female or no gender is provided: Values less than 10 are considered normal for postmenopausal females. Values from different assay methods may vary. The use of  this assay to monitor or to diagnose patients with cancer or any condition unrelated to pregnancy has not been approved by the FDA or the manufacturer of this assay.
Methodology: Immunoassay
Clinical Significance:

Monitoring patients for retained products of conception
Diagnosis of gestational trophoblastic disease (GTD), testicular tumors, ovarian germ cell tumors, teratomas, and, rarely, other human chorionic gonadotropin (hCG)-secreting tumors
Serial measurement of hCG following treatment to:
-Monitor therapeutic response in GTD or in hCG-secreting tumors
-Detect persistent or recurrent GTD or hCG-secreting tumors
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 3 to 5 days
Days Performed: Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Mayo Laboratory
PHL Test Code: HCGTM
EPIC Test Code: LAB752
Send Out Test Code: BHCG (61718)
Alternate Test Names: CG (Chorionic Gonadotropin); Chorionic Gonad, Beta-Subunit QN, Serum; Chorionic Gonadotropin Subunit HCG; Chorionic Gonadotropin, Beta-Subunit (Quantitative; Gonadotropins, Chorionic; HCG (Human Chorionic Gonadotropin) (Tumor Marker); Hcg Quantitative; hCG, Beta Subunit (Chorionic Gonad); hCG, Total QN; HCG,B-SUBUNIT(S); Human Chorionic Gonadotropins; Soft-HCGB
Included Tests:  
CPT Coding: 84702

Go back to the top of the page.